{
  "docId": "019de071-d756-7568-8588-410684bab010",
  "docSlug": "c18c99fc10f671fc397f8a743cdc0ce4",
  "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 23 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 23,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "The slide uses a process flow diagram to illustrate the clinical trial phases (randomization, treatment, extension).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-d756-7568-8588-410684bab010/6",
  "deckHref": "/decks/019de071-d756-7568-8588-410684bab010",
  "deckJsonHref": "/decks/019de071-d756-7568-8588-410684bab010.json",
  "deckAnchorHref": "/decks/019de071-d756-7568-8588-410684bab010#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.33,
        "w": 0.895,
        "x": 0.105,
        "y": 0.215
      },
      "kind": "diagram",
      "text": "Study flow diagram showing patient selection, 2:1 randomization, treatment arms (Pegzilarginase vs Placebo), and long-term extension.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "31d9f143-d473-4aee-9d85-9618a02c31c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.74,
        "x": 0.068,
        "y": 0.85
      },
      "kind": "disclaimer",
      "text": "Dosing is weekly and, if needed, dose is modified based on plasma arginine levels with maintenance of blinding. The first 8 weeks of the open-label extension will be blinded...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b28c9427-306a-48d5-87fe-a2ed1c5f0de8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.895,
        "x": 0.105,
        "y": 0.58
      },
      "kind": "table",
      "text": "Key Endpoints and Analysis table",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6c8075dc-645e-424c-b84f-a74d300d03dd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.39,
        "x": 0.068,
        "y": 0.045
      },
      "kind": "title",
      "text": "PEACE Phase 3 Study Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19f9e170-6d15-4526-8be9-3435d50ec101",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "clinical-trial-design",
      "slug": null,
      "matchId": "4d231bb0-68a2-4275-a485-6ce5027ec871",
      "evidence": "Standardized representation of patient randomization and study arms.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 5,
      "beatId": "e0d16f2c-c175-4c6a-8d80-f841a8242c55",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides present Pegzilarginase's efficacy in reducing arginine levels and improving mobility.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 5,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "81d36eb9-c56a-4571-9f51-feb9c7f6295f",
      "evidence": "Presents Pegzilarginase's benefits in managing arginine levels and improving patient outcomes.",
      "position": 1,
      "objective": "Demonstrates how Pegzilarginase meets the need for effective arginine reduction",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.7,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}